Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06170801
Other study ID # 457376358
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 2024
Est. completion date August 2026

Study information

Verified date March 2024
Source Charite University, Berlin, Germany
Contact Anne Guhn, Dr.
Phone +49 30 450 517456
Email anne.guhn@charite.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare an individual state-of-the-art cognitive behavioral therapy (CBT) with CBT augmented by a group intervention for improving interpersonal skills, the Kiesler Circle Training (CBT+KCT), in patients with a depressive or anxiety disorder.


Description:

This study aims to test the effectiveness and feasibility of a transdiagnostic group psychotherapy to improve interpersonal skills, the Kiesler Circle Training (KCT). For this purpose, a prospective, bicentre, randomised clinical trial (RCT) blinded by evaluators and statisticians will be conducted on outpatients with diagnoses of anxiety and/or depressive disorders according to DSM-5. An individual state-of-the-art cognitive behavioral therapy (CBT) will be compared with CBT augmented by Kiesler Circle Training (CBT + KCT) in a sample of 156 patients (CBT: 78 patients, CBT + KCT: 78 patients). All participants will be assessed four times, at baseline (T1, week 2), at mid-treatment (T2, week 9), at post-treatment (T3, week 14) and at 3-months follow-up (T4, week 26). Outcome measurements include interpersonal problems as well as symptom change in regard to both the categorical approach (primary diagnosis) and the transdiagnostic approach. The two main hypotheses are: 1. the improvement of interpersonal problems in the experimental group (CBT + KCT) will be greater than the improvement in the control group (CBT). 2. the improvement of interpersonal problems will be associated with decreasing symptom severity related to the primary diagnosis, so that patients in the conjoint CBT+KCT treatment will reach higher symptom change scores than patients in the CBT only condition. Furthermore, we assume that the course of interpersonal problems is moderated by childhood maltreatment and mediated by the quality and quantity of daily social contacts.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 156
Est. completion date August 2026
Est. primary completion date April 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Sufficient knowledge of the German language (B2 level) - Primary diagnosis of either depressive disorder or anxiety disorder according to DSM-5 at time of screening - Interpersonal distress above average (IIP-32 > 1.81) at time of screening - Ongoing individual CBT at time of screening - Signed informed consent regarding the study protocol Exclusion Criteria: - Acute suicidality at time of screening - Active substance abuse at time of screening - Borderline, antisocial, schizoid or schizotypic personality disorder at time of screening - Inability to participate in outpatient treatment with additional weekly group appointment at time of screening - Any kind of additional group treatment (including self-help groups) besides individual CBT during the entire study period

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Kiesler Circle Training (KCT)
Kiesler Circle Training is a transdiagnostic modular group treatment, which comprises a baseline module and four additional independent modules (nonverbal communication, verbal communication, conflict training and empathy and corrective interpersonal experiences). KCT is based on a heuristic model to explain and anticipate interactions developed by Donald Kiesler and other representatives of the interpersonal theory. The circumplex model arranges the variety of interpersonal behaviors in terms of a circular continuum allocated on two orthogonal axes: The vertical axis addresses interpersonal control (agency), the horizontal axis addresses interpersonal communion. The model further allows illustrating complementary action tendencies to anticipate other's reactions and to guide own behavior to achieve interpersonal goals. KCT is designed for increasing the awareness of such interpersonal action tendencies and for improving interpersonal behavioral flexibility.
Cognitive Behavioral Therapy (CBT)
Cognitive Behavioral Therapy is based on the interrelationships of thoughts, actions and feelings. Presumably, individual CBT will address intrapersonal therapeutic foci such as behavioral activation, identification of dysfunctional thoughts, overcoming fears by exposure, etc. Individual CBT may also include interpersonal functioning as therapeutic foci. Disorder-specific treatment manuals are available for all diagnoses included in the study. Of note, state-of-the-art CBT does not necessarily mean, that individual CBT-sessions strictly adhere to a manual. However, because both study sites are CBT training institutes, which guarantee supervision at least every four hours, it can be estimated that state-of-the-art CBT is realized.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Charite University, Berlin, Germany German Research Foundation, University of Greifswald

Outcome

Type Measure Description Time frame Safety issue
Other Childhood Trauma Questionnaire (CTQ; Original: Bernstein & Fink, 1998; German: Wingenfeld et al., 2010) Childhood maltreatment is assessed as a main moderator at baseline. The CTQ is a self-report assessment designed to measure experiences of childhood trauma and abuse on five subscales (emotional abuse, physical abuse, sexual abuse, emotional neglect and physical neglect). Patients rate the frequency of 34 of these experiences on a 5-point scale (1= not at all, 5 = very often), and each subscale score has a range from 5 to 25 points. Higher scores indicate a higher severity in childhood trauma. Baseline
Other Quality and quantity of daily social contacts Patients answer short questionnaires four times a day, which appear on their smartphone at random times (Electronical Momentary Assessment, EMA). The number of social contacts, the quality of social contacts (interpersonal complementarity), interaction partner, affect and anxiety are assessed. Three one-week EMA surveys (3 weeks in total: week 1-2, week 8-9, week 15-16)
Other Inventory for the Assessment of Negative Effects of Psychotherapy (INEP; Ladwig et al., 2014) The INEP is a self-report assessment of negative changes caused by psychotherapy in the areas of intrapersonal change, relationships, friendships, family, malpractice, and stigmatization. The INEP contains 21 items, which responses are partly formulated in a 7-point bipolar format (-3 = negative change is completely true, 0 = unchanged, 3 = positive change is completely true), and partly formulated in a 4-point unipolar format (0 = completely untrue; 3 = completely true). In addition, patients' attributions regarding the cause of negative effects is assessed. For the evaluation, only negative effects directly attributed to the psychotherapeutic treatment are considered. Weeks 1, 14, 26
Other Questionnaire for the Assessment of Side Effects and Negative Experiences in Group Therapy (NUGE- 24; Strauß & Drobinskaya, 2018) The NUGE assesses adverse experiences with group psychotherapy and side effects of the group setting by differentiating between group-related and therapist-related stress, stress from co-patients and personal overload. The NUGE comprises 24 items and responses are given on a 5-point scale (1 = strongly disagree, 5 = strongly agree), with higher scores indicating higher distress. The NUGE will be completed after each KCT group session by patients randomly assigned to the intervention group. Weekly during the weeks 3-14
Primary Inventory for Interpersonal Problems (IIP-32; Horowitz et al., 1988, German: Thomas et al., 2011) Change in interpersonal functioning, measured with the IIP-32 from baseline (Time 1) to week 14 (Time 2), represents the primary outcome measure. The IIP-32 is a self-assessment questionnaire for interpersonal problems, i.e., difficulties in interacting with other individuals, based on Horowitz's Circumplex Model. It consists of 32 items that are answered on a 5-point scale (0= not at all, 4 = very much). For evaluation, a mean score is calculated across all items, with a higher score indicating a higher severity of interpersonal problems. Weeks 1, 14
Secondary Inventory for Interpersonal Problems (IIP-32; Horowitz et al., 1988, German: Thomas et al., 2011) The IIP-32 is a self-assessment questionnaire for interpersonal problems, i.e., difficulties in interacting with other individuals, based on Horowitz's Circumplex Model. It consists of 32 items that are answered on a 5-point scale (0= not at all, 4 = very much). For evaluation, a mean score is calculated across all items, with a higher score indicating a higher severity of interpersonal problems. Baseline, Weeks 1, 9, 14, 26
Secondary Impact Message Inventory, revised version (IMI-R; Kiesler et al., 2006; German: Caspar et al., 2016) As key secondary endpoint, observer-rated changes in interpersonal functioning from Time 1 (week 1) to Time 2 (week 14) will be investigated with the IMI-R. The IMI-R will be conducted by blinded study raters. The IMI-R uses 64 items (8 items for each Kiesler Circle position) to capture covert reactions that a patient evokes in a blinded-rater. Through this assessment, it is possible to create an individual Kiesler Circle profile for each patient. The assessment of each behavior is conducted on a 4-point scale (1 = strongly disagree; 4 = strongly agree), so that higher values mean a higher expression of the Kiesler Circle position. Weeks 1, 14, 26
Secondary Hamilton Depression Rating Scale, 24 items version (HAM-D, Hamilton, 1967) The HAMD is a semi-structured interview, which measures the severity of depressive symptoms experienced in the last week. Blinded study raters will assess the severity of symptoms for each of the 24 items using a scale ranging from 0-2, 0-3, or 0-4. The total score ranges from 0-75, with higher scores indicating a higher severity of depression. Weeks 1, 9, 14, 26
Secondary Beck Depression Inventory, simplified (BDI-V; Beck, 1961; German version: Schmitt et al., 2000) The BDI-V is a self-report questionnaire designed to assess the severity of depressive symptoms. Patients rate the severity of 20 depression symptoms on a 6-point scale (0 = never, 5 = almost always). The total score ranges from 0 to 100, with higher scores indicating a higher severity of depression. Weeks 1, 9, 14, 26
Secondary Hamilton Anxiety Rating Scale (HAM-A; Hamilton, 1959) The HAM-A is a clinician-rating to assess the severity of anxiety symptoms experienced in the last week. Blinded raters will assess the severity of symptoms for each of 14 items using a 5-point scale ranging from 0 to 4. The total score ranges from 0 to 56, with higher scores indicating a higher severity of anxiety. Weeks 1, 9, 14, 26
Secondary Questionnaire on panic-related Anxieties, Cognitions and Avoidance (ACA; Chambless et al., 1984; German: Ehlers et al., 2001) The ACA is a self-report questionnaire of which we assess two subdomains in our study: the Body Sensations Questionnaire (BSQ) and the Agoraphobic Cognitions Questionnaire (ACQ). The BSQ asks about anxiety regarding 17 physical symptoms and the ACQ about 14 catastrophizing thoughts that can occur during anxiety. Answers are given on a 5-point scale, with higher scores indicating higher levels of anxiety (1 = not anxious/never, 5 = extremely anxious/always). A mean value is calculated for each of the two subdomains. Weeks 1, 9, 14, 26
Secondary Short Emotional Disorder Inventory (SEDI; adopted short version of the MEDI by Kaiser et al., unsubmitted) The SEDI is a short form of the Multidimensional Emotional Disorder Inventory (MEDI; Rosellini & Brown, 2019), which represents a dimensional approach to classify emotional disorders. The SEDI is a self-report questionnaire comprising 15 items that are answered on a 4-point scale (1 = completely untrue or slightly true, 4 = completely true). A mean value is calculated over all items, with higher values indicating a higher level of emotional disorder traits. Weeks 1, 14, 26
Secondary Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001) The PHQ-9 is part of the Patient Health Questionnaire and measures depressive symptoms using 9 items. The rating scale is 4-point (0 = never, 3 = almost daily) and a total score ranging from 0-24 is calculated. Weeks 1, 14, 26
Secondary Patient Health Questionnaire-15 (PHQ-15; Kroenke et al., 2002) The PHQ-15 is part of the Patient Health Questionnaire and measures the 15 most common somatic symptoms of outpatients. The rating scale is 3-point (0 = not affected, 2 = severely affected) and a total score ranging from 0-30 is calculated. Weeks 1, 14, 26
Secondary Generalized Anxiety Disorder 7 (GAD-7; Spitzer et al., 2006) The GAD-7 was integrated into the patient health questionnaire in 2006 as a validated scale for measuring generalized anxiety disorder using 7 items. The rating scale is 4-point (0 = never, 3 = almost daily) and a total score ranging from 0-21 is calculated. Weeks 1, 14, 26
Secondary World Health Organization Quality of Life (WHOQoL-BREF; The WHOQOL Group, 1998) The WHOQoL-BREF is a self-report measure and assesses the subjective quality of life across physical, psychological, social, and environmental domains using 26 items. These domains are rated by patients on a 5-point scale and a mean score for each domain is calculated by multiplying the mean value of all items of the respective domain by four. The possible values for all domain scores therefore range from 4-20. Weeks 1, 14, 26
Secondary Personality Inventory for DSM-5 Brief Form Plus (PID5BF+M; Bach et al., 2020) The PID5BF+M is a self-report questionnaire designed to assess maladaptive personality traits in alignment with the DSM-5 and ICD-11. The questionnaire comprises 36 items, which are answered on a 4-point scale (0 = completely untrue, 3 = completely true) and captures six personality trait domains (negative affectivity, detachment, antagonism/dissociality, disinhibition, anankastia, and psychoticism). A mean value is calculated for each domain, with higher scores indicating higher expression of that personality domain. Weeks 1, 14, 26
Secondary Level of Personality Functioning Scale-Brief Form 2.0 (LPFS-BF; Spitzer et al., 2021) The LPFS-BF is a self-report questionnaire designed to assess personality functioning in alignment with the DSM-5 and ICD-11. The questionnaire comprises 12 items, which are answered on a 4-point scale (1 = completely untrue, 4 = completely true) and captures two personality functioning domains (self and interpersonal pathology). A mean value is calculated for each domain, with higher scores indicating higher expression of that personality functioning domain. Weeks 1, 14, 26
Secondary Interpersonal Needs Questionnaire (INQ; Forkmann, T. & Glaesmer, H., 2013) The Interpersonal Needs Questionnaire (INQ) measures interpersonal needs using two subscales: thwarted belongingness and perceived burdensomeness. The questionnaire consists of 15 items, that are answered on a 7-point scale (1 = completely untrue, 7 = completely true). After reversing the polarity of 6 items, a mean value is calculated for each of the two subscales, with higher scores indicating higher levels of thwarted belongingness and perceived burdensomeness. Weeks 1, 14, 26
See also
  Status Clinical Trial Phase
Completed NCT01316926 - Paxil CR Bioequivalence Study Brazil Phase 1
Recruiting NCT06187454 - Transcranial Direct Current Stimulation for Depression N/A
Completed NCT04469322 - Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression N/A
Recruiting NCT05768126 - Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine Phase 4
Completed NCT03219879 - Telephone-administered Relapse Prevention for Depression N/A
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Completed NCT03043560 - Study to Treat Major Depressive Disorder With a New Medication Phase 2
Completed NCT04091139 - Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong Phase 2/Phase 3
Completed NCT00069459 - Seasonal Affective Depression (SAD) Study Phase 1
Recruiting NCT05503966 - Combining Antidepressants and Attention Bias Modification in Depression N/A
Recruiting NCT03001245 - Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents N/A
Completed NCT02939560 - TMS for Adults With Autism and Depression N/A
Completed NCT02542891 - European Comparative Effectiveness Research on Internet-based Depression Treatment N/A
Completed NCT02452892 - Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Withdrawn NCT02238730 - Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy N/A
Completed NCT02306551 - Well Being And Resilience: Mechanisms of Transmission of Health and Risk
Completed NCT01407575 - Buprenorphine for Treatment Resistant Depression Phase 3
Completed NCT01597661 - Bupropion & Cardio Birth Defect (Slone) N/A
Completed NCT01093053 - Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations N/A